Discover
BTAI
BioXcel Therapeutics, Inc.
0.07
1 x 0.16
1 x 0.12
bid
ask
+
0.00
0.00%
1 @ 04:00 PM
1.30 +1.23 (1659.13%)
| Ytd | -95.38% | |
| 1y | -96.36% |
0.07
day range
0.09
0.30
52 week range
4.17
| Open | 0.09 | Prev Close | 0.07 | Low | 0.07 | High | 0.09 | Mkt Cap | 16.98M |
| Vol | 47.48M | Avg Vol | 616.96K | EPS | -2.04 | P/E | N/A | Forward P/E | -0.21 |
| Beta | 0.29 | Short Ratio | 0.93 | Inst. Own | 8.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-26 | 50-d Avg | 0.53 | 200-d Avg | 1.28 | 1yr Est | 5.00 |
| Income Statement | |||
| Total Revenue | 182.00K | ||
| Revenues (USD) | 182.00K | ||
| Cost of Revenue | 22.00K | ||
| Gross Profit | 160.00K | ||
| Operating Expenses | 10.35M | ||
| Research and Development Expense | 3.16M | ||
| Selling, General and Administrative Expense | 7.19M | ||
| Operating Income | -10.19M | ||
| Interest Expense | 4.26M | ||
| Net Income | -14.71M | ||
| Net Income Common Stock | -14.71M | ||
| Net Income Common Stock (USD) | -14.71M | ||
| Consolidated Income | -14.71M | ||
| Earnings per Basic Share | -0.49 | ||
| Earnings per Basic Share (USD) | -0.49 | ||
| Earnings per Diluted Share | -0.49 | ||
| Earning Before Interest & Taxes (EBIT) | -10.46M | ||
| Earning Before Interest & Taxes (USD) | -10.46M | ||
| Weighted Average Shares | 30.30M | ||
| Weighted Average Shares Diluted | 30.30M | ||
| Balance Sheet | |||
| Cash and Equivalents | 13.80M | ||
| Cash and Equivalents (USD) | 13.80M | ||
| Trade and Non-Trade Receivables | 82.00K | ||
| Current Assets | 28.70M | ||
| Property, Plant & Equipment Net | 99.00K | ||
| Total Assets | 28.80M | ||
| Debt Current | 104.45M | ||
| Total Debt | 104.45M | ||
| Current Liabilities | 137.15M | ||
| Total Liabilities | 144.26M | ||
| Accumulated Retained Earnings (Deficit) | -747.50M | ||
| Shareholders Equity | -115.46M | ||
| Shareholders Equity (USD) | -115.46M | ||
| Assets Non-Current | 99.00K | ||
| Total Debt (USD) | 104.45M | ||
| Inventory | 483.00K | ||
| Liabilities Non-Current | 7.11M | ||
| Trade and Non-Trade Payables | 18.94M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 18.00K | ||
| Net Cash Flow from Financing | 2.72M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.38M | ||
| Issuance (Purchase) of Equity Shares | 3.05M | ||
| Issuance (Repayment) of Debt Securities | -304.00K | ||
| Net Cash Flow from Operations | -6.10M | ||
| Share Based Compensation | 358.00K | ||